MedPath

The comparison of the efficacy of two therapeutic regimens in the treatment of gastroesophageal reflux disease in term neonates.

Not Applicable
Not yet recruiting
Conditions
Gastroesophageal Reflux.
Gastro-oesophageal reflux disease
Registration Number
IRCT20160827029535N10
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
120
Inclusion Criteria

Term neonates aged 1–30 days with gastro esophageal reflux disease

Exclusion Criteria

Neonates with any underlying diseases, including anomalies or gastrointestinal obstruction, neurological disorders, sepsis, NEC, etc.
History of using any sedative , relaxant or anticonvulsive medications
History of ventilation therapy.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The comparison of omeprazole with lansoprazole in neonatal GERD. Timepoint: One week and one month after using each drug. Method of measurement: using (I-GERDQ-R) and related scoring.
Secondary Outcome Measures
NameTimeMethod
The side effects of each drug. Timepoint: After one week and one month of administration. Method of measurement: Clinical manifestations.
© Copyright 2025. All Rights Reserved by MedPath